Avelumab

ATC L01FF04 · 10 markets · 14 records

Avelumab 10 markets · 14 records Forms

AU 3 records · 3 strengths

200 mg/10 mLinjectionBAVENCIO also in GB·SG
20 mg/mLinjectionBAVENCIO avelumab (rch) 200 mg/10 mL concentrated solution for intravenous infusion vial unknown

Records without a stated strength · 1 BAVENCIO

ES 3 records · 1 strengths

20 mg/1 mLinjectionBAVENCIO

US 1 records · 1 strengths

20 mginjectionBAVENCIO also in TW

GB 1 records · 1 strengths

200 mg/10 mLinjectionBavencio 200mg/10ml concentrate for solution for infusion vials also in AU·SG

CA 1 records · 1 strengths

20 mgliquidBAVENCIO

SG 1 records · 1 strengths

200 mg/10 mLinjectionBAVENCIO CONCENTRATE FOR SOLUTION FOR INFUSION 200MG/10ML also in AU·GB

TW 1 records · 1 strengths

20 mginjectionBavencio 20mg/mL Concentrate for Solution for Infusion+1百穩益注射劑20毫克/毫升 also in US

HK 1 records · 1 strengths

Records without a stated strength · 1 BAVENCIO CONCENTRATE FOR SOLUTION FOR INFUSION 200MG/10ML

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 BAVENCIO

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	TW	HK	EU
200 mg/10 mL injection	not recorded	Bavencio 200mg/10ml concentrate for solution for infusion vials	not recorded	BAVENCIO	BAVENCIO CONCENTRATE FOR SOLUTION FOR INFUSION 200MG/10ML	not recorded	not recorded	not recorded	not recorded
20 mg injection	BAVENCIO	not recorded	not recorded	not recorded	not recorded	not recorded	Bavencio 20mg/mL Concentrate for Solution for Infusion 百穩益注射劑20毫克/毫升	not recorded	not recorded
20 mg liquid	not recorded	not recorded	BAVENCIO	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
20 mg/1 mL injection	not recorded	not recorded	not recorded	not recorded	not recorded	BAVENCIO	not recorded	not recorded	not recorded
20 mg/mL injection	not recorded	not recorded	not recorded	BAVENCIO avelumab (rch) 200 mg/10 mL concentrated solution for intravenous infusion vial	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	BAVENCIO	not recorded	not recorded	not recorded	BAVENCIO CONCENTRATE FOR SOLUTION FOR INFUSION 200MG/10ML	BAVENCIO

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in CA · ES and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · ES que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · ES 有记录（未在本表显示）。另有 2 個規格/劑型僅在 CA · ES 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.